Figure 3. Patients survival in relation to ESR1 PvuII and UGT2B15*2 polymorphisms in tamoxifen-treated patients.
Disease-free survival (A) and overall survival (B) are shown in respective panels.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.